340B Discounts at Risk In 2025 and Beyond

Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawThe 340B Drug Pricing Program faces intensifying scrutiny and legal battles at both state and federal levels in 2025. Pharmacy benefit managers (PBMs) are tightening point-of-sale claim identification, states are enacting anti-discrimination protections, and covered entities are waiting for the next shoe to drop.“Depending on who you’re speaking with, 340B is either the greatest thing since sliced